PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
63.05%
Net income growth above 1.5x MRVL's 5.00%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
23.85%
Some D&A expansion while MRVL is negative at -0.85%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-1703.67%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
50.87%
Less working capital growth vs. MRVL's 439.52%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
-200.91%
Negative yoy inventory while MRVL is 653.82%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-12.57%
Negative yoy usage while MRVL is 431.90%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
13.91%
Growth of 13.91% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
144.30%
Operating cash flow growth below 50% of MRVL's 5620.88%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-296.61%
Both yoy lines negative, with MRVL at -92.43%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.02%
Growth well above MRVL's 46.54%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
49.26%
We have mild expansions while MRVL is negative at -167.50%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
403.64%
Lower share issuance yoy vs. MRVL's 906.32%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
No Data
No Data available this quarter, please select a different quarter.